Addressing Recruitment Challenges
Patient recruitment remains a critical challenge, particularly in therapeutic areas requiring specific demographic profiles or Rare Disease populations.
These site partnerships demand efficient and timely patient recruitment with a focus on access to diverse patient populations which enhances trial efficiency and regulatory compliance.
Gabriel Kremmidiotis, Chief Scientific Officer at Avance Clinical, underscores the importance of diverse site partnerships: “Accessing a global site network allows biotechs to tap into varied patient demographics and therapeutic expertise. This diversity is crucial for meeting enrollment targets efficiently.”
The Role of Global Site Partnership Networks
At the forefront of this strategy is Avance Clinical, recognized for its extensive global site partnership network. This network spans key regions, including Australia, Asia, Europe and the United States, strategically positioning Avance Clinical as a trusted partner for biotechs seeking comprehensive trial solutions.
Yvonne Lungershausen, CEO of Avance Clinical, emphasizes the strategic advantage of such networks: “Our global site partnership network is designed to optimize patient recruitment by leveraging local expertise and infrastructure. This approach not only accelerates trial timelines but also enhances data quality and regulatory adherence.”
